Dermatology Advisor

Circulating Tumor HPV DNA May Aid Risk Assessment With Oropharyngeal Cancer

Circulating tumor HPV DNA levels were linked to clinical risk in patients having surgery for HPV-related oropharyngeal cancer.
Medscape

Blood-Based HPV Test Detects Oropharyngeal Cancer Early

A novel multifeature human papillomavirus (HPV) whole genome sequencing liquid biopsy assay detected circulating tumor HPV DNA (ctHPV DNA) with 79% sensitivity and 100% specificity up to 7.8 years ...
ABC News

DNA-Based HPV Tests More Accurate Than Pap Smears

Mar. 26 -- TUESDAY, March 25 (HealthDay News) -- A new study confirms previous findings that human papillomavirus (HPV) DNA-based tests are more accurate than Pap smears in detecting precancerous ...
Medical Xpress

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...
Seeking Alpha

PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research

Data confirms Versamune ® HPV has potential as a broadly effective treatment of HPV16-associated cancers – Initiation of Phase 3 trial in HPV16-positive HNSCC planned for Q1 2025 Versamune ® HPV + CRT ...